Vendor, Newark, CA
Malcova Inc.
UEI GSB6L7B1FB13, CAGE 9BXA8
1 award and $1,004,344 obligated between June 3, 2026 and June 3, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $1,004,344 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40126C00019Definitive Contract, June 3, 2026, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Proposed Research Qualifies as Development (Per Its Definition in FAR 35.001) as Primary Focus of the Proposed Project Is on Developing a DiNAICS 541715, PSC AJ12 | $1,004,344 |
- Places of performance
- California
- Product and service codes
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research
- Transactions
- 1 across 1 awards